Sobi
在场
Sobi 的所有者是 Investor AB.
是其中之一......
Investor AB 是一家在股票代码 INVEb.ST (SE) 下上市的公司。
Investor AB 在 6 个国家有直接业务。Investor AB 拥有 13家子公司，其中包括 Advanced Instruments、Kunskapsskolan 和 Molnlycke Health Care。
他们在：
涉及Investor AB的并购和融资。
- Sobi 已收购 CTI BioPharma (公布2023六月27号).
- Sobi has announced the acquisition of CTI BioPharma (公布2023五月10号).
高管
查看带有其 55 名主要高管的组织结构图
Sobi 搜索最多的简介
- Guido Oelkers, President and Chief Executive Officer
- Helena Saxon, Director
- Annette Clancy, Chairman of the Board (becomes Director on Dec 1 2...
高管在Sobi变化
- David MeekDavid Meek 将于202412月1作为 Chairman of the Board 加入公司 (新闻发布的2024十一月5号).
- Zlatko Rihter已作为Director加入公司 (新闻发布的2024五月16号).
高管在Investor AB变化
- Jenny Haquinius, will join the company as Chief Financial Officer (新闻发布的2024八月29号).
- Helena Saxon, Chief Financial Officer, 将于 20256月30 退休 (新闻发布的2024六月4号).
- Christian Cederholm已作为Director加入公司 (新闻发布的2024五月8号).
创建提醒
跟踪 Sobi 的高管变动
药店
Investor AB 拥有 1,834 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Sobi 的最新新闻稿
- Bulletin from Sobi's Extraordinary General Meeting (EGM)
- Sobi's strength in haematology to be showcased at ASH 2024
- Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)
- David Meek is proposed as new Chair of the Board of Directors of Sobi
- New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference
- Pivotal VALIANT results presented at Kidney Week show pegcetacoplan treatment effect in patients with C3G / primary IC-MPGN
- Invitation: Sobi's Aspaveli® and the Phase 3 VALIANT data in Nephrology call
- Sobi Q3 2024 report: Strong growth and significant pipeline momentum
- New number of shares and votes in Sobi
- Press releases
- View more press releases Close
通过电子邮件
